Cellular and extracellular biology of the latent transforming growth factor-β binding proteins

Matrix Biology

Volumn 17, Issue 8-9, 1998, Pages 529-545

  Sinha, Sanjay ^a   Nevett, Claire ^a   Shuttleworth, C Adrian ^a   Kielty, Cay M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Extracellular matrix; Fibrillin; Transforming growth factor

Indexed keywords

FIBRILLIN; GLYCOPROTEIN; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

AMINO ACID SEQUENCE; CARCINOGENESIS; COMPLEX FORMATION; EXTRACELLULAR MATRIX; FIBROSIS; GENE STRUCTURE; HUMAN; INFLAMMATION; PRIORITY JOURNAL; PROTEIN DOMAIN; REVIEW; SEQUENCE HOMOLOGY;

EID: 0032415040     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0945-053X(98)90106-8     Document Type: Short Survey

References (72)

1. Bashir, M. M., Han, M.-D., Abrams, W. R., Tucker, T., Ma, R.-I., Gibson, M., Ritty, T., Mecham, R. and Rosenbloom, J.: Analysis of the human gene encoding latent transforming growth factor-β-binding protein-2. Int. J. Biochem. Cell Biol. 28:531-542, 1996.
2. Bonewald, L. F., Wakefield, L., Oreffo, R. O., Escobedo, A., Twardzik, D. R. and Mundy, G. R.: Latent forms of transforming growth factor-beta (TGF beta) derived from bone cultures: Identification of a naturally occurring 100-kDa complex with similarity to recombinant latent TGF beta. Molec. Endocrinol. 5: 741-751, 1991.
3. Border W. A,. Okuda S., Languino L. R., Sporn M. B. and Ru oslahti E.: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor-β1. Nature 346:371-373, 1990.
4. Brandes, M. E., Wakefield, L. M. and Wahl, S. M.: Modulation of monocyte type-I transforming growth factor-beta receptors by inflammatory stimuli. J. Biol. Chem. 266: 19297-19703, 1991.
5. Colosetti, P., Hellman, U., Heldin, C.-H. and Miyazono, K.: Calcium binding of latent transforming growth factor-β1 binding protein. FEBS Lett. 320: 140-144, 1993.
6. Dahlback, B., Hildebrand, B. and Linse, S.: Novel type of very high affinity calcium-binding sites in β-hydroxyasparagine-contaming epidermal growth factor-like domains in vitamin K-dependent protein S. J. Biol. Chem.: 265, 18481-18489, 1990.
7. Dallas, S. L., Park-Snyder, S., Miyazono, K., Twardzik, D., Mundy, G. R. and Bonewald, L. F.: Characterization and autoregulation of latent transforming growth factor-β (TGF-β) complexes in osteoblast-like cell lines. J. Biol. Chem. 269: 6815-6822, 1994.
8. Dallas, S. L., Miyazono, K., Skerry, T. M., Mundy, G. R. and Bonewald, L. F.: Dual role for the transforming growth factor-β binding protein in storage of latent TGF-β in the extracellular matrix and as a structural matrix protein. J. Cell Biol.: 131: 539-549, 1995.
9. Dennis, P. A. and Rifkin, D. B.: Cellular activity of latent transforming growth factor beta requires binding to the cation-independent mannose-6-phosphate insulin-like growth factor type II receptor. Proc. Natl. Acad. Sci. USA 88: 580-584, 1991.
10. Downing, A. K., Knott, V., Werner, J. M., Cardy, C. M., Campbell, I. D. and Handford, P. A.: Solution structure of a pair of calcium-binding epidermal growth factor-like domains: Implications for the Marfan syndrome and other genetic disorders. Cell 85: 597-605, 1996.
11. Fklöv, S., Funa, K., Nordgren, H., Olofsson, A., Kanzaki, T., Miyazono, K. and Nilsson, S.: Lack of the latent transforming growth factor âbinding protein in malignant, but not benign prostatic tissue. Canc. Res. 53: 3193-3197, 1993.
12. Fang, J., Li, X., Smiley, E., Francke, U., Mecham, R. P. and Bonadio, J.: Mouse latent TGF-β binding protein-2: molecular cloning and developmental expression. Biochim. Biophys. Acta 1354: 219-230, 1997.
13. Flaumenhaft, R., Abe, M., Sato, Y., Miyazono, K., Harpel, J., Heldin, C-H. and Rifkin, D. B.: Role of the latent TGF-β binding protein in the activation of latent TGF-β by co-cultures of endothelial and smooth muscle cells. J. Cell Biol. 320:995-1002, 1993.
14. Gibson, M. A., Hatzinikolas, G., Davis, E. C., Baker, E., Sutherland, G. R. and Mecham, R. P.: Bovine latent transforming growth factor (1 binding protein 2: Molecular cloning, identification of tissue isoforms, and immunolocalisation to elastin-associated microfibrils. Molec. Cell. Biol. 15: 6932-6942, 1995.
15. Giltay, R., Kostka, G. and Timpl, R.: Sequence and expression of a novel member (LTBP-4) of the family of latent transforming growth factor-( binding proteins. FEBS Lett. 411: 164-168, 1997.
16. Glanville, R. W., Qian, R. Q., McClure, D. W. and Maslen, C. L.: Calcium binding, hydroxylation, and glycosylation of the precursor epidermal growth factor-like domains of fibrillin-1, the Marfan gene protein. J. Biol. Chem. 269: 26630-26634, 1994.
17. Gleizes, P.-E., Beavis, R. C., Mazzieri, R., Shen, B. and Rifkin, D. B.: Identification and characterisation of an eight-cysteine repeat of latent transforming growth factor-( binding protein-1 that mediates bonding to the latent transformign growth factor-(1. J. Biol. Chem. 27: 29891-29896, 1996.
18. Gong, W., Roth, S., Michel, K. and Gressner, A. M.: Isoforms and splice variants of transforming growth factor β-binding protein in rat hepatic stellate cells. Gastroenterol. 114: 352-363, 1998.
19. Handford, P. A., Baron, M., Mayhew, M., Wills, A., Beesley, T., Brownlee, G. G. and Campbell, I. D.: The first EGF-like domain from human factor IX contains a high-affinity calcium binding site. EMBO J. 9: 475, 1990.
20. Handford, P., Downing, A. K., Rao, Z., Hewett, D. R., Sykes, B. C. and Kielty, C. M.: The calcium binding properties and molecular organisation of epidermal growth factor-like domains in human fibrillin-1. J. Biol. Chem. 270: 6751-6756, 1995.
21. Henriksen, R., Gobi, A., Wilander, E., Oberg, E., Miyazono, K. and Funa, K.: Expression and prognostic significance of TGF-β isotypes, latent TGF-β1 binding protein, TGF-β type-I and type-II receptors, and endoglin in normal ovary and ovarian neoplasms. Lab. Invest. 73: 213-220, 1995.
22. Hyytiäinen, M., Taipale, J., Heldin, C.-H. and Keski-Oja, J.: Recombinant latent transforming growth factor β-binding protein 2 assembles to fibroblast extracellular matrix and is susceptible to proteolytic processing and release. J. Biol. Chem. 273: 20669-20676, 1998.
23. Hommel, U., Harvey, T. S., Driscoll, P. C. and Campbell, I. D.: Human epidermal growth factor: High resolution solution structure and comparison with human transforming growth factor. J. Molec. Biol. 227: 271-282, 1992.
24. Kanzaki, T., Olofsson, A., Morén, A., Wernstedt, C., Hellman, U., Miyazono, K., Claesson-Welsh, L. and Heldin, C.-H.: TGE-β1 binding protein: a component of the large latent complex of TGF-β1 with multiple repeat sequences. Cell 61: 1051-1061, 1990.
25. Kanzaki, T., Shiina, R., Saito, Y., Oohashi, H. and Morisaki, N.: Role of latent TGF-β1 binding protein in vascular remodeling. Biochem. Biophys. Res. Comm. 246: 26-30, 1998.
26. Karonen, T, Jeskanen, L. and Keski-Oja, J.: Transforming growth factor-β1 and its latent form binding protein-1 associate with elastic fibres in human dermis: accumulation in actinic damage and absence in anetoderma. Brit. J. Dermatol. 137: 51-58, 1997.
27. Kojima, S., Kiyomitsu, N., and Rifkin, D. B.: Requirement for transglutaminase in the activation of latent transforming growth factor-β in bovine endothelial cells. J. Cell Biol. 121: 439-448, 1993.
28. Lawrence, D.A., Pircher, R. and Jullien, P.: Conversion of a high molecular weight latent β-TGF from chicken embryo fibroblasts into a low molecular weight active β-TGF under acidic conditions. Biochem. Biophys. Res. Comm. 133, 1026-1034, 1985.
29. Li, X., Yin, W., Perez-Jurado, L., Bonadio, J. and Franke, U.: Mapping of human and murine genes for latent TGF-β binding protein-2 (LTBP2). Mammal. Genome 6: 42-45, 1995.
30. Miyazono, K., Hellman, U., Wernstedt, C. and Heldin, C.-H.: Latent high molecular weight complex of transforming growth factor (1. J. Biol. Chem. 263: 6407-6415, 1988.
31. Miyazono, K., Thyberg, J. and Heldin, C.-H.: Retention of the transforming growth factor-b1 precursor in the Golgi complex in a latent endoglycosidase H-sensitive form. J. Biol. Chem. 267: 5668-5675, 1992.
32. Mizoi, T., Ohtani, H., Miyazono, K., Matsuno, S. and Nagura, H.: Immunoelectron microscopic localisation of transforming growth factor β1 and latent transforming growth factor β1 binding protein in human gastrointestinal carcinomas: Qualitative difference between cancer cells and stromal cells. Canc. Res. 53: 183-190, 1993.
33. Morén, A., Olofsson, A., Stenman, G., Sahlin, P., Kanzaki, T., Claesson-Welsh, L., ten Dijke, P., Miyazono, K. and Heldin, C.-H.: Identification and characterisation of LTBP-2, a novel latent transforming growth factor-( binding protein. J. Biol. Chem. 269: 32469-32476, 1994.
34. Munger, J. S., Harpel, J. G., Gleives, P.-E., Mazzieri, R., Nunes, I. and Rifkin, D. B.: Latent transforming growth factor-β: structural features and mechanisms of activation. Kidney Int. 51: 1376-1382, 1997.
35. Munger, J. S., Harpel, J. G., Giancotti, F. G. and Rifkin, D. B.: Interactions between growth factors and integrins: latent forms of transforming growth factor-β are ligands for the integrin αvβ1 Molec. Biol. Cell 9: 2627-2638, 1998.
36. Nakajima, Y., Miyazono, K., Kato, M., Takase, M., Yamagishi, T. and Nakamura, H.: Extracellular fibrillar structure of latent TGFβ binding protein-1: role in TGFβ-dependent endothelial-mesenchymal transformation during endocardial cushion tissue formation in mouse emblyonic heart. J. Cell Biol. 136: 193-204, 1997.
37. Nunes, I., Gleizes, P-E., Metz, C. N. and Rifkin, D. B.: Latent transforming growth factor-β binding protein domains involved in activation and transgltaminase-dependent cross-linking of latent transforming growth factor-β. J. Cell Biol. 136: 1151-1163, 1997.
38. Ohlin, A. K., Linse, S. and Stenflo, J.: Calcium binding to the epidermal growth factor homology region of bovine protein C. J. Biol. Chem. 263: 7411 -7417, 1988.
39. O'Kane, S. and Ferguson, M. J. W.: Transforming growth factor βs and wound healing. Int. J. Biochem. Cell Biol. 29: 63-78, 1997.
40. Öklü, R., Metcalfe, J. C., Hesketh, T. R. and Kemp, P. R.: Loss of a consensus heparin binding site by alternative splicing of latent transforming growth factor-( binding protein-1. FEBS Lett. 425:281-285, 1998.
41. Olofsson, A., Miyazono, K., Kanzaki, T., Closetti, P., Engstrom, U. and Heldin, C-H.: Transforming growth factor-β1, -β2, and -β3 secreted by a human glioblastoma cell line. Identification of small and different forms of large latent complexes. J. Biol. Chem. 267: 19482-19488, 1992.
42. Olofsson, A., Ichijo, H., Morén, A., ten Dijke, P., Miyazono, K. and Heldin, C.H.: Efficient association of an amino-terminally extended form of human latent transforming growth factor-( binding potein with the extracellular matrix. J. Biol. Chem. 70:31294-31297, 1995.
43. Olofsson, A., Hellman, U., Ten-Dijke, P., Grimsby, S., Ichijo, H., Moren, A., Miyazono, K. and Heldin, C-H.: Latent transforming growth factor-β complex in Chinese hamster ovary cells contains the multifunctional cysteme-rich fibroblast growth factor receptor, also termed F-selectin-ligand or MG-160. Biochem. J., 324: 427-434, 1997.
44. Persson, E., Selander, M., Linse, S., Drakenberg, T., Ohlin, A. and Stenflo, J.: Calcium binding to the isolated β-hydroxyasparric acid-containing epidermal growth factor-like domain of bovine factor X. J. Biol. Chem. 264: 16897-16904, 1989.
45. Pfaff, M., Reinhardr, D. P., Sakai, L. Y. and Timpl, R.: Cell-adhesion and integrin binding to recombinant human fibrillin-1. FEBS Lett. 384: 247-250, 1996.
46. Pircher, R., Jullien, P. and Lawrence, D. A.: β-transforming growth factor is stored in human platelets as a latent high molecular weight complex. Biochim. Biophys. Res. Acta, 13: 30-37, 1986.
47. 2+-binding epidermal growth factor-like domain: Its role in protein-protein interactions. Cell 8, 131-141, 1995.
48. Raghunath, M., Tschodrich Rotter, M., Unsold, C., Peters, R., BrucknerTuderman, L. and Meuli, M.: Fibrillin-containing microfibrils of normal and regenerating skin contain latent transforming growth factor-binding protein-1 (LTBP-1) and are a repository for latent TGF-beta 1. J. Invest. Dermatol. 110: 62-66, 1998.
49. Ramirez, F.: Fibrillin mutations in Marian syndrome and related phenotypes. Curr. Opin. Genet. Develop. 6: 309-315, 1996.
50. Reinhardt, D.P., Mechling, D.E., Boswell, B.A., Keene, D.R., Sakai, L.Y. and Bachinger, N.P.: Calcium determines the shape of fibrillin. J Biol. Chem. 272: 7368-7373, 1997a.
51. Reinhardt, D.P., Ono, R.N. and Sakai, L.Y.: Calcium stabilises fibrillin-1 against proteolytic degradation. J Biol. Chem. 272: 2: 1231-1236, 1997b.
52. Roberts A. B., Anzano M. A., Lamb I,. C., Smith J. M. and Sporn M. B.: New class of transforming growth factors potentiated by epidermal growth factor: isolation from nonneoplastic tissues. Proc. Natl. Acad. Sci. USA 78:5339-5343, 1991.
53. Roberts AB and Sporn MB.: Physiological actions and clinical applications of transforming growth factor-beta (TGF-β). Growth Factors 8: 1-9, 1983.
54. Saharinen, J., Taipale, J., and Keski-Oja, J.: Association of the small latent transforming growth factor-) with an eight cysteine repeat of its binding protein LTBP-1. EMBO J. 15: 245-253, 1996.
55. Saharinen, J., Taipale, J., Monni, O. and Keski-Oja, J.: Identification and characterisation of a new latent transforming growth factor-β-binding protein, LTBP-4. J. Biol. Chem. 273:18459-18469, 1998.
56. Sakai, L.Y., Keene, D.R. and Engvall, K.: Fibrillin, a new 350-kDa glycoprotein, is a component of extracellular microfibrils. J Cell Biol 103: 2499-2509, 1986.
57. Sakamoto, H., Broekelmann, T., Cheresh, D. A., Ramirez, F., Rosenbloom, J. and Mecham, R.P.: Cell-type specific recognition of RGD- and non-RGD-containing cell binding domains in fibrillin-1. J. Biol. Chem. 271: 4916-4922, 1996.
58. 2+-free form of the amino-terminal epidermal growth factor like domain in coagulation factor X. Biochem. 29; 8111, 1990.
59. 2-terminal EGF-like domain n coagulation factor X. J. Biol. Chem. 26: 19642-19649, 1992.
60. Stenflo, J.: Structure-function relationships of epidermal growth factor modules in vitamin K-dependent clotting factors. Blood 78: 1637-1651, 1991.
61. Stenman, G., Sahlin, A., Olofsson, A., Geurts van Kessel, K., and Miyazono, K. Assignment of the gene encoding the latent TGF-beta-1-binding protein (LTBP1) to human chromosome 2.region p12-q22. Cytogenet. Cell Genet. 66; 117-119, 1994.
62. Taipale, J., Miyazono, K. Heldin, C.-H. and Keski-Oja, J.: Latent transforming growth factor-β1 associates to fibroblast extracellular matrix via latent TGF-β binding protein. J. Cell Biol. 124: 171-181, 1994.
63. Taipale, J., Saharinen, J., Hedman, K. and Keski-Oja, J.: Latent transforming growth factor-β1 and its binding protein are components of extracellular matrix microfibrils. J. Histochem. Cytochem. 44: 875-889, 1996.
64. Taketazu, F., Kato, M., Gobl, A., Ichijo, H., Tendijke, P., Itoh, J. P., Kyogoku, M., Ronnelid, J., Miyazono, K., Heldin, C.-H. and Funa, K.: Enhanced expression of transforming growth factor-β and transforming growth factor-β type-II receptor in the synovial tissues of patients with rheumatoid arthritis. Lab. Invest. 70: 620-630, 1994.
65. Tamaki, K., Okuda, S., Ando, T., Iwamoto, T., Nakayama, M. and Fujishima, M.: TGF-β1 in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathy. Kidney Int. 45: 525-536, 1994.
66. Tsuji, T., Okada, F., Yamaguchi, K., and Nakamura, T. molecular cloning of the large subunit of transforming growth factor type β masking protein and expression of the mRNA in various rat tissues. Proc. Natl. Acad. Sci. USA 87: 8835-8839, 1990.
67. Wakefield, L. M., Smith, D. M., Flanders, K. C. and Sporn, M. B.: Latent transforming growth factor-β from human platelets: a high molecular weight complex containing precursor sequences. J. Cell Biol. 105: 965-975, 1988.
68. Wess, T. J., Purslow, P. P., Sherratt, M. J., Ashworth, J. L., Shuttleworth, C. A. and Kielty, C. M.: calcium determines the supramolecular organisation of fibrillin-rich microfibrils. J. Cell Biol. 141: 829-837, 1998.
69. Yin, W., Smiley, E., Germiller, J., Mecham, R. P., Florer, J. B., Wenstrup, R. J. and Bonadio, J.: Isolation of a novel latent transforming growth factor-( binding protein gene (LTBP-3). J. Biol. Chem. 270: 10147-10160, 1995.
70. Yin, W., Smiley, E. and Bonadio, J.: Alternative splicing of LTBP-3. Biochem. Biophys. Res. Comm. 245: 454-458, 1998a.
71. Yin, W., Fang, J., Smiley, E. and Bonadio, J.: 8-Cysteine TGF-BP structural motifs are the site of covalent binding between mouse LTBP-3, LTBP-2, and latent TGF-β1. Biochim. Biophys. Acta, 1383, 340-350, 1998b.
72. Yuan, X., Downing, A. K., Knott, V. and Handford, P. A.: Solution structure of the transforming growth factor β-binding module. A domain associated with matrix fibrils. EMBO J. 16: 6659-6666, 1997.